Lauri Markkanen scores 33, rallies the Jazz to a 116-114 win over the Mavericks

SALT LAKE CITY (AP) — Lauri Markkanen had 33 points and seven rebounds and the Utah Jazz snapped a five-game losing streak with a 116-114 victory over the Dallas Mavericks on Thursday night.

Keyonte George added 19 points and seven assists. Brice Sensabaugh scored 14 points and Kevin Love chipped in 10 points and 10 boards.

Cooper Flagg had 29 points, 10 rebounds, and eight assists to lead Dallas. Klay Thompson made six 3-pointers and scored 23 points off the bench. Anthony Davis added 21 points and 11 rebounds for the Mavs.

Utah scored 25 points off 21 Dallas turnovers and outscored the Mavericks 64-46 in the paint.

Dallas scored baskets on four straight possessions, culminating in Max Christie’s 3-pointer, to take a 107-100 lead with 4:39 left. Utah then held the Mavericks without a basket for nearly four minutes and surged into the lead.

Markkanen scored three straight baskets to fuel a 12-0 run that gave the Jazz a 112-107 lead with 1:41 left. Utah scored on seven of its final nine possessions to secure the victory.

Utah’s willingness to attack the rim early paid off. The Jazz scored 24 of their 34 first-quarter points in the paint. It sparked a 22-6 run that helped Utah to a 27-17 lead. Cody Williams fueled the run with three dunks over four possessions.

The Jazz led by as many as 14 points in the second quarter, going up 53-39 after Markkanen capped a 15-5 run with a dunk.

Dallas chipped away at the deficit and took a 61-60 lead after Naji Marshall and Christie hit back-to-back 3-pointers to open the third quarter.

Mavericks: At Chicago on Saturday.

Jazz: Host Charlotte on Saturday.

AP NBA: https://apnews.com/hub/nba

Utah Jazz forward Lauri Markkanen, center left, blocks the shot of Dallas Mavericks forward Anthony Davis, center right, during the first half of an NBA basketball game, Thursday, Jan. 8, 2026, in Salt Lake City. (AP Photo/Tyler Tate)

Dallas Mavericks forward Anthony Davis, center right, shoots over Utah Jazz forward Lauri Markkanen (23) during the first half of an NBA basketball game, Thursday, Jan. 8, 2026, in Salt Lake City. (AP Photo/Tyler Tate)

Dallas Mavericks forward Anthony Davis (3) drives to the basket while guarded by Utah Jazz forward Cody Williams (5) during the first half of an NBA basketball game, Thursday, Jan. 8, 2026, in Salt Lake City. (AP Photo/Tyler Tate)

Dallas Mavericks forward Cooper Flagg (32) shoots over Utah Jazz forward Lauri Markkanen (23) during the first half of an NBA basketball game, Thursday, Jan. 8, 2026, in Salt Lake City. (AP Photo/Tyler Tate)

NEW YORK--(BUSINESS WIRE)--Jan 9, 2026--

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260109769684/en/

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

Shares of Aquestive Therapeutics, Inc. (NASDAQ: AQST) plunged approximately 40% intraday on Friday after the company disclosed that the U.S. Food and Drug Administration (FDA) identified deficiencies in its New Drug Application (NDA) for Anaphylm, its experimental sublingual film for the treatment of severe allergic reactions, including anaphylaxis. The FDA advised that the unidentified deficiencies currently prevent discussions of labeling and post-marketing requirements, raising concerns about the application’s approvability ahead of the January 31, 2026, PDUFA action date.

To learn more about the Aquestive Therapeutics investigation, go to www.faruqilaw.com/AQST or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics